{
 "PrintNo":"A10369","Session":2021,"Chamber":"ASSEMBLY","BillType":"Assembly","Published":"2022-05-13T13:19:45.189516Z",
 "Status":"IN_ASSEMBLY_COMM","Committee":"Economic Development",
 "Milestones":[{"Type":"IN_ASSEMBLY_COMM","Date":"2022-05-13","Committee":"Economic Development"}],
 "Actions":[{"Text":"REFERRED TO ECONOMIC DEVELOPMENT","Date":"2022-05-13","Chamber":"ASSEMBLY"}],
 "Sponsors":[
  {"ID":1461,"Name":"Keith Brown","Short":"BROWN K"},{"ID":480,"Name":"David McDonough","Short":"MCDONOUGH"},
  {"ID":1238,"Name":"Joe DeStefano","Short":"DESTEFANO"},{"ID":1481,"Name":"Joe Angelino","Short":"ANGELINO"}
 ],
 "Title":"Requires certain businesses in which alcohol or cannabis is consumed have opioid antagonists",
 "Summary":"Requires retail licensees for on-premises consumption of alcohol and adult-use on-site consumption of cannabis licensees have opioid antagonists to be administered to patrons, staff or individuals on premises of such establishment.",
 "LawSection":"Alcoholic Beverage Control Law","LawCode":"Amd ยง106, ABC L; amd ยง77, Cannabis L",
 "ActClause":"AN ACT to amend the alcoholic beverage control law and the cannabis law, in relation to requiring certain businesses in which alcohol or cannabis is consumed to have opioid antagonists"
}